Cited by 355Gastrointestinal motility and disordersGut microbiota and healthInflammatory Bowel Disease

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome

Open access

Atkinson, Wendy, Lockhart, Stephen, Whorwell, Peter J., Keevil, Brian, Houghton, Lesley A.·2006·Gastroenterology

DOI 10.1053/j.gastro.2005.09.031

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Evidence suggests that postprandial platelet-depleted plasma 5-hydroxytryptamine (5-HT) concentrations may be abnormal in irritable bowel syndrome (IBS). However, interpretation of the data has been hampered by the variable methodology and rather small numbers used in previous studies. Therefore, the aim of this study was to measure concentrations of platelet-depleted plasma 5-HT and its metabolite 5-HIAA under fasting and fed conditions in a large group of patients with diarrhea-predominant (d-) and constipation-predominant (c-) IBS, compared with controls. The ratio of plasma 5-HIAA:5-HT and platelet stores was also assessed.Methods Twenty-nine c-IBS patients (aged, 19-53 years), 55 d-IBS patients (aged, 19-52 years), and 35 healthy volunteers (aged, 18-46 years) had platelet-depleted plasma 5-HT/5-HIAA concentrations measured using reverse-phase, high-performance liquid chromatography with fluorimetric detection before and after a standard meal.Results d-IBS patients had raised platelet-depleted plasma 5-HT concentrations under fasting and fed conditions (P < .05). However, the postprandial relative to fasting concentration was similar to controls. In contrast, c-IBS patients failed to show an increase in platelet-depleted plasma 5-HT concentration with meal ingestion compared with controls (P < .01). c-IBS was associated with decreased 5-HIAA (P < .01) but normal 5-HIAA:5-HT ratio and d-IBS with normal 5-HIAA concentrations but reduced 5-HIAA:5-HT ratio (P < .005). C-IBS but not d-IBS patients had increased platelet 5-HT.Conclusions These results support the concept that d-IBS is characterized by reduced 5-HT reuptake, whereas impaired release may be a feature of c-IBS. These results also provide a rational basis for current pharmacologic approaches involving modulation of different 5-HT receptors in c- and d-IBS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2005.09.031

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1 ☆
Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J. C., Blaszyk, H., Crowell, M. D., Sharkey, K. A., Gershon, M. D., & Mawe, G. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.013 · Cited by 761
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Cocaine, Ethanol, and Genotype Effects on Human Midbrain Serotonin Transporter Binding Sites and mRNA Levels
Little, K. Y., McLaughlin, D. P., Zhang, L., Livermore, C. S., Dalack, G. W., McFinton, P. R., DelProposto, Z., Hill, E. M., Cassin, B. J., Watson, S. J., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.207 · Cited by 382
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.
Cann, P. A., Read, N. W., Brown, C., Hobson, N., & Holdsworth, C. D. (1983) · Gut · doi:10.1136/gut.24.5.405 · Cited by 365
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C., Singh, G., Marsden, C. A., & Spiller, R. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00726-8 · Cited by 355
Colonic Motility Abnormality in Patients With Irritable Bowel Syndrome Exhibiting Abdominal Pain and Diarrhea
Chey, W. Y., Jin, H. O., Lee, M. H., Sun, S. W., & Lee, K. Y. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03804.x · Cited by 347
The motility of the pelvic colon
Connell, A. M. (1962) · Gut · doi:10.1136/gut.3.4.342 · Cited by 315
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study
Bearcroft, C. P., Perrett, D. I., & Farthing, M. J. G. (1998) · Gut · doi:10.1136/gut.42.1.42 · Cited by 303

Show all 41 references

Research works printed but not linked: 1

Whitaker, 1996, Measurement of platelet rich plasma 5-HT and platelet poor plasma 5-HIAA and 5-HT in normal adults, Ann Clin Biochem, 537, 341

Sorted by citations

The serotonin signaling system: from basic understanding to drug development for functional GI disorders
Gershon, M. D., & Tack, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.002 · Cited by 1,563
Serotonin signalling in the gut: functions, dysfunctions and therapeutic targets
Mawe, G. M., & Hoffman, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.105 · Cited by 1,165
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Self-citation
Pathophysiology of irritable bowel syndrome
Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30023-1 · Cited by 590
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Self-citation
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
Camilleri, M., Lasch, K. L., & Zhou, W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2012 · Cited by 412
Pathophysiology of Fibromyalgia
Bradley, L. A. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.09.008 · Cited by 366
How important is tryptophan in human health?
Kałużna-Czaplińska, J., Gątarek, P., Chirumbolo, S., Chartrand, M. S., & Bjørklund, G. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357534 · Cited by 333
Gastrointestinal Tract Disorders in Older Age
Dumic, I., Nordin, T., Jecmenica, M., Lalošević, M. S., Milosavljević, T., & Milovanovic, T. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6757524 · Cited by 348
Diagnosis and treatment of chronic constipation - a European perspective
Tack, J. F., Müller-Lissner, S. A., Stanghellini, V., Boeckxstaens, G. E., Kamm, M. A., Simrén, M., Galmiche, J., & Fried, M. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01709.x · Cited by 307
Role of serotonin in gastrointestinal motility and irritable bowel syndrome
Sikander, A., Rana, S. V., & Prasad, K. K. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.028 · Cited by 286
Enterochromaffin Cells of the Human Gut: Sensors for Spices and Odorants
Braun, T., Voland, P., Kunz, L., Prinz, C., & Gratzl, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.036 · Cited by 264
Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
Ford, A. C., Brandt, L. J., Young, C., Chey, W. D., Foxx-Orenstein, A. E., & Moayyedi, P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.223 · Cited by 261
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome
Camilleri, M., McKinzie, S., Busciglio, I. A., Low, P. A., Sweetser, S. R., Burton, D. D., Baxter, K. L., Ryks, M. D., & Zinsmeister, A. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.060 · Cited by 244
Serotonin and GI clinical disorders
Spiller, R. E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.016 · Cited by 240
S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)
Layer, P., Andresen, V., Pehl, C., Allescher, H. ‐., Bischoff, S., Claßen, M., Enck, P., Frieling, T., Haag, S., Holtmann, G., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0029-1245976 · Cited by 236
Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome
Cremon, C., Carini, G., Wang, B., Vasina, V., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Grundy, D., Tonini, M., De Ponti, F., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.86 · Cited by 223
Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones
Méleine, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6725 · Cited by 220
Clinical significance of lymph node metastasis in gastric cancer
Deng, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3967 · Cited by 198
Role of infection in irritable bowel syndrome
Spiller, R. C. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1925-8 · Cited by 187
Irritable bowel syndrome: Emerging paradigm in pathophysiology
Lee, Y. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2456 · Cited by 190
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
Öhman, L., Törnblom, H., & Simrén, M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.200 · Cited by 185
Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview
Holtmann, G., Shah, A., & Morrison, M. (2018) · Digestive Diseases · doi:10.1159/000485409 · Cited by 163
Serotonin in the gastrointestinal tract
Camilleri, M. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32831e9c8e · Cited by 175
IBS and IBD — separate entities or on a spectrum?
Spiller, R. E., & Major, G. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.141 · Cited by 170
Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5‐HT signalling and metabolism in human disease
Spiller, R. E. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00965.x · Cited by 164
Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea
Camilleri, M., Sellin, J. H., & Barrett, K. E. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.014 · Cited by 165
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Xiao, L., Liu, Q., Luo, M., & Xiong, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.729346 · Cited by 168
Metabolite Profiles During Oral Glucose Challenge
Ho, J. E., Larson, M. G., Vasan, R. S., Ghorbani, A., Cheng, S. C., Rhee, E. P., Florez, J. C., Clish, C. B., Gerszten, R. E., & Wang, T. J. (2013) · Diabetes · doi:10.2337/db12-0754 · Cited by 160
Serotonin Signaling Is Altered in Irritable Bowel Syndrome With Diarrhea but Not in Functional Dyspepsia in Pediatric Age Patients
Faure, C. C., Patey, N., Gauthier, C., Brooks, E. M., & Mawe, G. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.032 · Cited by 154
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome
Öhman, L., & Simrén, M. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.10.014 · Cited by 155
Impaired Uptake of Serotonin by Platelets From Patients With Irritable Bowel Syndrome Correlates With Duodenal Immune Activation
Foley, S., Garsed, K. C., Singh, G., Duroudier, N. P., Swan, C., Hall, I. P., Zaitoun, A. M., Bennett, A. J., Marsden, C. A., Holmes, G. K. T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.052 · Cited by 140
Brain-Gut Interactions in IBS
Fichna, J., & Storr, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00127 · Cited by 146
Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives
Lesurtel, M., Soll, C., Graf, R., & Clavien, P. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7377-3 · Cited by 138
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome
Stasi, C., Bellini, M., Bassotti, G., Blandizzi, C., & Milani, S. (2014) · Techniques in Coloproctology · doi:10.1007/s10151-013-1106-8 · Cited by 139
Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis
Labus, J. S., Osadchiy, V., Hsiao, E. Y., Tap, J., Derrien, M., Gupta, A., Tillisch, K., Nevé, B. L., Grinsvall, C., Ljungberg, M., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0656-z · Cited by 136
Mycobacterium avium Subspecies paratuberculosis Infection in Cases of Irritable Bowel Syndrome and Comparison with Crohn's Disease and Johne's Disease: Common Neural and Immune Pathogenicities
Scanu, A. M., Bull, T. J., Cannas, S., Sanderson, J. D., Sechi, L. A., Dettori, G., Zanetti, S., & Hermon-Taylor, J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01371-07 · Cited by 133
Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell–Prostaglandin E2
Gao, J., Xiong, T., Grabauskas, G., & Owyang, C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.016 · Cited by 131
Management Options for Irritable Bowel Syndrome
Camilleri, M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.032 · Cited by 140
Alterations in Expression of p11 and SERT in Mucosal Biopsy Specimens of Patients With Irritable Bowel Syndrome
Camilleri, M., Andrews, C. N., Bharucha, A. E., Carlson, P. J., Ferber, I. J., Stephens, D. A., Smyrk, T. C., Urrutia, R. A., Aerssens, J., Thielemans, L. A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.020 · Cited by 127
Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders
Fukui, H., Xu, X., & Miwa, H. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18071 · Cited by 128
Rome III Functional Constipation and Irritable Bowel Syndrome With Constipation Are Similar Disorders Within a Spectrum of Sensitization, Regulated by Serotonin
Shekhar, C., Monaghan, P. J., Morris, J., Issa, B., Whorwell, P. J., Keevil, B. G., & Houghton, L. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.014 · Cited by 2,891
Self-citation
The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
Sun, Y.-Y., Li, M., Li, Y.-Y., Li, L.-X., Zhai, W.-Z., Wang, P., Yang, X.-X., Gu, X., Song, L.-J., Li, Z., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21241-z · Cited by 126
5-HT in the enteric nervous system: gut function and neuropharmacology
McLean, P. G., Borman, R. A., & Lee, K. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.11.002 · Cited by 124
Serotonin pharmacology in the gastrointestinal tract: a review
Beattie, D. T., & Smith, J. A. M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0276-9 · Cited by 121
Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1
Hu, D., Zhu, G., Mori, F., Omoe, K., Okada, M., Wakabayashi, K., Kaneko, S., Shinagawa, K., & Nakane, A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00957.x · Cited by 120
The Measurement of Platelet-Poor Plasma Serotonin: A Systematic Review of Prior Reports and Recommendations for Improved Analysis
Brand, T., & Anderson, G. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.163824 · Cited by 124
New Insights into the Pathogenesis and Pathophysiology of Irritable Bowel Syndrome
Collins, S. M. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3314-6_9 · Cited by 115
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
Camilleri, M., & Katzka, D. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2011 · Cited by 117
Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism
Grifka‐Walk, H. M., Jenkins, B. R., & Kominsky, D. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653208 · Cited by 115
Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.
Beatty, J. K., Bhargava, A., & Buret, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3976 · Cited by 292
Enteromorpha and polysaccharides from enteromorpha ameliorate loperamide-induced constipation in mice
Ren, X., Liu, L., Gamallat, Y., Zhang, B., & Xin, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.119 · Cited by 106
Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome
Akiho, H. (2010) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v1.i3.97 · Cited by 112
The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma
Makharia, A., Catassi, C., & Makharia, G. K. (2015) · Nutrients · doi:10.3390/nu7125541 · Cited by 105
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis
Carco, C., Young, W., Gearry, R. B., Talley, N. J., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00468 · Cited by 105
Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms
Camilleri, M. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.270892 · Cited by 98
Meta‐analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome
van Kerkhoven, L. A. S., Laheij, R. J. F., & Jansen, J. B. �. �. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03453.x · Cited by 93
Serotonin transporter gene polymorphism and irritable bowel syndrome
Park, J. M., Choi, M., Park, J., Oh, J. H., Cho, Y. K., Lee, I. S., Kim, S. W., Choi, K.-Y., & Chung, I. ‐. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00829.x · Cited by 91
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
Chey, W. D., Maneerattaporn, M., & Saad, R. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.3.253 · Cited by 89
Mast cells and nerves tickle in the tummy
Rijnierse, A., Nijkamp, F. P., & Kraneveld, A. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.008 · Cited by 105
Alterations in serotonin metabolism in the irritable bowel syndrome
Thijssen, A. Y., Mujagic, Z., Jonkers, D. M. A. E., Ludidi, S., Keszthelyi, D., Hesselink, M., Clemens, C. H. M., Conchillo, J. M., Kruimel, J. W., & Masclee, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13459 · Cited by 84
Irritable bowel syndrome
Talley, N. J. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01217.x · Cited by 87
Enteroendocrine cell regulation of the gut-brain axis
Barton, J. R., Londregan, A., Alexander, T. D., Entezari, A. A., Covarrubias, M., & Waldman, S. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1272955 · Cited by 95
Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders
Sharma, A., Rao, S. S. C., Kearns, K., Orleck, K. D., & Waldman, S. A. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16369 · Cited by 84
Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter
Haub, S., Ritze, Y., Bergheim, I., Pabst, O., Gershon, M. D., & Bischoff, S. C. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01479.x · Cited by 80
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016
Layer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 81
Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota
Gu, Y., Wang, C., Qin, X., Zhou, B., Liu, X., Liu, T., Xie, R., Liu, J., Wang, B., & Cao, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106291 · Cited by 76
Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission
Vannucchi, M. G., & Evangelista, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7010004 · Cited by 75
QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells
Doihara, H., Nozawa, K., Kojima, R., Kawabata-Shoda, E., Yokoyama, T., & Ito, H. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0165-7 · Cited by 72
Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway
Li, Y., Qi, X., Tong, X., & Wang, S. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.32 · Cited by 72
The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies
Zhang, Z., Duan, Z., Wang, L.-X., Yang, D., Zhao, G., & Zhang, L. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-23 · Cited by 71
New insights into irritable bowel syndrome: from pathophysiology to treatment
Hadjivasilis, A. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0428 · Cited by 76
Mucosal serotonin signaling is altered in chronic constipation, but not in opiate-induced constipation
Costedio, M., Coates, M., Brooks, E. M., Glass, L. M., Ganguly, E., Blaszyk, H., Ciolino, A. L., Wood, M. J., Strader, D., Hyman, N., et al. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.683 · Cited by 93
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Depression, Anxiety and Anger in Subtypes of Irritable Bowel Syndrome Patients
Muscatello, M. R. A., Bruno, A., Pandolfo, G., Micò, U., Stilo, S. A., Scaffidi, M., Consolo, P., Tortora, A., Pallio, S., Giacobbe, G., et al. (2010) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-009-9182-7 · Cited by 64
Relationship between overactive bladder and irritable bowel syndrome: a large‐scale internet survey in J apan using the overactive bladder symptom score and Rome III criteria
Matsumoto, S., Hashizume, K., Wada, N., Hori, J., Tamaki, G., Kita, M., Iwata, T., & Κakizaki, H. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11591.x · Cited by 63
Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: Relation to serotonin and psychological state
Keszthelyi, D., Troost, F. J., Jonkers, D. M. A. E., Kruimel, J. W., Leue, C., & Masclee, A. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.008 · Cited by 62
Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls.
Kumar, S., Ranjan, P., Mittal, B., & Ghoshal, U. C. (2012) · PubMed · Cited by 61
Serotonin Augments Gut Pacemaker Activity via 5-HT3 Receptors
Liu, H.-N., Ohya, S., Nishizawa, Y., Sawamura, K., Iino, S., Syed, M. M., Goto, K., Imaizumi, Y., & Nakayama, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024928 · Cited by 65
Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin
Xu, Y., Wang, J., Wu, X., Jing, H., Zhang, S., Hu, Z., Rao, L., Chang, Q., Wang, L., & Zhang, Z. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2168101 · Cited by 61
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome
Gargari, G., Mantegazza, G., Cremon, C., Taverniti, V., Valenza, A., Barbaro, M., Marasco, G., Duncan, R., Fiore, W., Ferrari, R., et al. (2024) · Gut microbes · doi:10.1080/19490976.2023.2298246 · Cited by 55
Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19
Jin, B., Singh, R., Ha, S. E., Zogg, H., Park, P. J., & Ro, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i19.2341 · Cited by 59
Sex as a biological variable in irritable bowel syndrome
Camilleri, M. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13802 · Cited by 60
Intestinal epithelial barrier and neuromuscular compartment in health and disease
D’Antongiovanni, V., Pellegrini, C., Fornai, M., Colucci, R., Blandizzi, C., Antonioli, L., & Bernardini, N. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i14.1564 · Cited by 63
Peripheral factors in the pathophysiology of irritable bowel syndrome
Gunnarsson, J., & Simrén, M. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.006 · Cited by 57
Genetic epidemiology of irritable bowel syndrome
Makker, J. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11353 · Cited by 57
Review article: new receptor targets for medical therapy in irritable bowel syndrome
Camilleri, M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04153.x · Cited by 57
Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome
Keszthelyi, D., Troost, F. J., Jonkers, D. M. A. E., van Eijk, H. M. H., Lindsey, P. J., Dekker, J. P., Buurman, W. A., & Masclee, A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12842 · Cited by 53
The Serotonin Transporter Polymorphism rs25531 Is Associated with Irritable Bowel Syndrome
Kohen, R., Jarrett, M. E., Cain, K. C., Jun, S., Navaja, G. P., Symonds, S., & Heitkemper, M. M. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0666-3 · Cited by 53
Toward manipulating serotonin signaling via the microbiota–gut–brain axis
Everett, B. A., Tran, P., & Prindle, A. B. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102826 · Cited by 52
Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment
CHANG, J. Y., & Talley, N. J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.04.008 · Cited by 53
Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders
Camilleri, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13351 · Cited by 50
LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin
Camilleri, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01643.x · Cited by 50
Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
Camilleri, M. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.794223 · Cited by 50
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism
Barbaro, M. R., Sabatino, A. D., Cremon, C., Giuffrida, P., Fiorentino, M., Altimari, A., Bellacosa, L., Stanghellini, V., & Barbara, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00368.2015 · Cited by 50
The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review
den Houte, K. V., Scarpellini, E., Verbeure, W., Mori, H., Schol, J., Masuy, I., Carbone, F., & Tack, J. F. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00172 · Cited by 51
Serotonin is elevated in COVID-19-associated diarrhoea
Ha, S. E., Jin, B., Clemmensen, B., Park, P., Mahboob, S., Gladwill, V., MADHANI-LOVELY, F. K., Gottfried‐Blackmore, A., Habtezion, A., Verma, S. C., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323542 · Cited by 50
Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome
Christmas, D. M., Badawy, A. A. ‐., Hince, D., Davies, S., Probert, C. S., Creed, T., Smithson, J., Afzal, M., Nutt, D., & Potokar, J. P. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.09.009 · Cited by 48
Pharmacotherapy for Irritable Bowel Syndrome
Camilleri, M., & Ford, A. C. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6110101 · Cited by 53
5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex
Niesler, B., Kapeller, J., Fell, C., Atkinson, W., Möller, D., Fischer, C., Whorwell, P. J., & Houghton, L. A. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832e9d6b · Cited by 48
Self-citation

Authors: Atkinson, W., Lockhart, S., Whorwell, P. J., Keevil, B., & Houghton, L. A.
Corresponding author: Houghton, Lesley A.
ORCID: Whorwell, Peter J.
Keevil, Brian
Houghton, Lesley A.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2006-01
Volume: 130
Issue: 1
Pages: 34-43
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2005.09.031
OpenAlex: W2128077096
Cited by: 355
References: 41
Citations by year: 2026: 10 · 2025: 11 · 2024: 15 · 2023: 21 · 2022: 20 · 2021: 30 · 2020: 18 · 2019: 12 · 2018: 11 · 2017: 15 · 2016: 15 · 2015: 12 · 2014: 30 · 2013: 16 · 2012: 20
FWCI: 18.47
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion, other-oa)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords: irritable bowel syndrome, irritable bowel syndrome with constipation, diarrhea-predominant irritable bowel syndrome, serotonin, 5-hydroxyindoleacetic acid, serotonin uptake, serotonin release, serotonin receptors
MeSH terms: Adult, Chromatography, High Pressure Liquid, Constipation, Diarrhea, Fasting, Female, Humans, Hydroxyindoleacetic Acid, Male, Middle Aged, Serotonin, Signal Transduction, Case-Control Studies, Postprandial Period, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks